Effects of initiating a contraceptive implant on subsequent condom use: A randomized controlled trial

Contraception

Volumn 92, Issue 6, 2015, Pages 560-566

  Rattray, Carole ^a   Wiener, Jeffrey ^b   Legardy Williams, Jennifer ^b   Costenbader, Elizabeth ^c   Pazol, Karen ^b   Medley Singh, Natalie ^a   Snead, Margaret C ^a   Steiner, Markus J ^c   Jamieson, Denise J ^b   Warner, Lee ^b   Gallo, Maria F ^d   Hylton Kong, Tina ^e   Kourtis, Athena P ^b  

^a UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Ministry of Health   (Jamaica)

Author keywords

Condom use; Contraceptive implant; LARC; PSA; Randomized controlled trial

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; BIOLOGICAL MARKER; CONTRACEPTIVE AGENT; DRUG IMPLANT;

ADULT; ANTIGEN DETECTION; ARTICLE; CONDOM USE; CONTROLLED STUDY; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; JAMAICAN; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUALLY TRANSMITTED DISEASE; UNPLANNED PREGNANCY; UNPROTECTED SEX; ADVERSE EFFECTS; CHEMISTRY; CONDOM; CONTRACEPTION; CONTRACEPTIVE BEHAVIOR; DRUG IMPLANT; FOLLOW UP; JAMAICA; MALE; OUTPATIENT DEPARTMENT; PREGNANCY; PROCEDURES; PSYCHOLOGY; SAFE SEX; SEXUALLY TRANSMITTED DISEASES; SPERM; UNSAFE SEX; UTILIZATION; VAGINA; YOUNG ADULT;

ADULT; AMBULATORY CARE FACILITIES; BIOMARKERS; CONDOMS; CONTRACEPTION; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAMAICA; MALE; PREGNANCY; PREGNANCY, UNPLANNED; PROSTATE-SPECIFIC ANTIGEN; SAFE SEX; SEMEN; SEXUALLY TRANSMITTED DISEASES; UNSAFE SEX; VAGINA; YOUNG ADULT;

EID: 84960494453     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2015.06.009     Document Type: Article

References (46)

1. G. Sedgh, S. Singh, and R. Hussain Intended and unintended pregnancies worldwide in 2012 and recent trends Stud Fam Plann 45 3 2014 301 314
2. S. Singh, G. Sedgh, and R. Hussain Unintended pregnancy: worldwide levels, trends, and outcomes Stud Fam Plann 41 4 2010 241 250
3. P. Dixit, F. Ram, and L.K. Dwivedi Determinants of unwanted pregnancies in India using matched case-control designs BMC Pregnancy Childbirth 12 2012 84
4. H.H. Le, M.P. Connolly, L. Bahamondes, J.G. Cecatti, J. Yu, and H.X. Hu The burden of unintended pregnancies in Brazil: a social and public health system cost analysis Int J Womens Health 6 2014 663 670
5. R.B. Kaufmann, L. Morris, and A.M. Spitz Comparison of two question sequences for assessing pregnancy intentions Am J Epidemiol 145 9 1997 810 816
6. P.D. Blumenthal, A. Voedisch, and K. Gemzell-Danielsson Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception Hum Reprod Update 17 1 2011 121 137
7. L.B. Finer, J. Jerman, and M.L. Kavanaugh Changes in use of long-acting contraceptive methods in the United States, 2007-2009 Fertil Steril 98 4 2012 893 897
8. J. Trussell, N. Henry, F. Hassan, A. Prezioso, A. Law, and A. Filonenko Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception Contraception 87 2 2013 154 161
9. J.J. Speidel, C.C. Harper, and W.C. Shields The potential of long-acting reversible contraception to decrease unintended pregnancy Contraception 78 3 2008 197 200
10. B. Winner, J.F. Peipert, Q. Zhao, C. Buckel, T. Madden, J.E. Allsworth, and et al. Effectiveness of long-acting reversible contraception N Engl J Med 366 21 2012 1998 2007
11. M. Ott, and G. Sucato Committee on Adolescence Contracept Adolesc 29 2014
12. A.C.O.G. Committee Opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy Obstet Gynecol 114 6 2009 1434 1438
13. World Health Organization Medical eligibility criteria for contraceptive use 2010 World Health Organization
14. D.A. Grimes Forgettable contraception Contraception 80 6 2009 497 499
15. I. Mavranezouli, and C. Wilkinson Long-acting reversible contraceptives: not only effective, but also a cost-effective option for the National Health Service J Fam Plann Reprod Health Care 32 1 2006 3 5
16. W. Cates, and M.J. Steiner Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? Sex Transm Dis 29 3 2002 168 174
17. A. Glasier Should healthcare professionals be advocating long-acting reversible contraception? Womens Health (Lond Engl) 5 1 2009 1 4
18. K. Pazol, M.R. Kramer, and C.J. Hogue Condoms for dual protection: patterns of use with highly effective contraceptive methods Public Health Rep 125 2 2010 208 217
19. J.S. Santelli, M. Davis, D.D. Celentano, A.D. Crump, and L.G. Burwell Combined use of condoms with other contraceptive methods among inner-city Baltimore women Fam Plann Perspect 27 2 1995 74 78
20. P.D. Darney, L.S. Callegari, A. Swift, E.S. Atkinson, and A.M. Robert Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception Am J Obstet Gynecol 180 4 1999 929 937
21. L.F. Cushman, D. Romero, D. Kalmuss, A.R. Davidson, S. Heartwell, and M. Rulin Condom use among women choosing long-term hormonal contraception Fam Plann Perspect 30 5 1998 240 243
22. D.L. Eisenberg, J.E. Allsworth, Q. Zhao, and J.F. Peipert Correlates of dual-method contraceptive use: an analysis of the National Survey Of Family Growth (2006-2008) Infect Dis Obstet Gynecol 2012 2012 717163
23. C.F. Roye Condom use by Hispanic and African-American adolescent girls who use hormonal contraception J Adolesc Health 23 4 1998 205 211
24. M. Polaneczky, G. Slap, C. Forke, A. Rappaport, and S. Sondheimer The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers N Engl J Med 331 18 1994 1201 1206
25. H.C. Graves, G.F. Sensabaugh, and E.T. Blake Postcoital detection of a male-specific semen protein. Application to the investigation of rape N Engl J Med 312 6 1985 338 343
26. L. Kamenev, M. Leclercq, and C. Francois-Gerard An enzyme immunoassay for prostate-specific p30 antigen detection in the postcoital vaginal tract J Forensic Sci Soc 29 4 1989 233 241
27. M.L. Lawson, M. Maculuso, A. Bloom, G. Hortin, K.R. Hammond, and R. Blackwell Objective markers of condom failure Sex Transm Dis 25 8 1998 427 432
28. M. Macaluso, L. Lawson, R. Akers, T. Valappil, K. Hammond, R. Blackwell, and et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure Contraception 59 3 1999 195 201
29. Shanghai Dahua Pharmaceutical Company L. Sino-Implant (II) [package insert] 1996 [Shanghai, China]
30. N.K. Tepper, P.A. Marchbanks, and K.M. Curtis Use of a checklist to rule out pregnancy: a systematic review Contraception 87 5 2013 661 665
31. R. Jamshidi, A. Penman-Aguilar, J. Wiener, M.F. Gallo, J.M. Zenilman, J.H. Melendez, and et al. Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA Contraception 88 6 2013 749 757
32. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials BMC Med 8 2010 18
33. M.M. Hobbs, M.J. Steiner, K.D. Rich, M.F. Gallo, A. Alam, M. Rahman, and et al. Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research Sex Transm Dis 36 8 2009 501 506
34. M.F. Gallo, M.C. Snead, C.M. Black, T.M. Brown, A.P. Kourtis, D.J. Jamieson, and et al. Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies Contraception 87 6 2013 830 835
35. C. Anderson, M.F. Gallo, T. Hylton-Kong, M.J. Steiner, M.M. Hobbs, M. Macaluso, and et al. Randomized controlled trial on the effectiveness of counseling messages for avoiding unprotected sexual intercourse during sexually transmitted infection and reproductive tract infection treatment among female sexually transmitted infection clinic patients Sex Transm Dis 40 2 2013 105 110
36. S.H. Jung, and C.W. Ahn Sample size for a two-group comparison of repeated binary measurements using GEE Stat Med 24 17 2005 2583 2596
37. R.L. Williams, and J.D. Fortenberry Dual use of long-acting reversible contraceptives and condoms among adolescents J Adolesc Health 52 4 Suppl 2013 S29 S34
38. A.B. Berenson, and C.M. Wiemann Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study Am J Obstet Gynecol 172 4 Pt 1 1995 1128 1135
39. M.F. Gallo, L. Warner, D.J. Jamieson, and M.J. Steiner Do women using long-acting reversible contraception reduce condom use? A novel study design incorporating semen biomarkers Infect Dis Obstet Gynecol 2011 2011 107140
40. G.S. Stuart, and D.A. Grimes Social desirability bias in family planning studies: a neglected problem Contraception 80 2 2009 108 112
41. Methodological Challenges in Biomedical HIV Prevention Trials S. Lagakos, and A. Gable 2008 National Academies Press Washington, DC
42. S.M. Noar, C. Cole, and K. Carlyle Condom use measurement in 56 studies of sexual risk behavior: review and recommendations Arch Sex Behav 35 3 2006 327 345
43. J.A. Catania, D.R. Gibson, D.D. Chitwood, and T.J. Coates Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior Psychol Bull 108 3 1990 339 362
44. J.L. Walsh, R.L. Fielder, K.B. Carey, and M.P. Carey Dual method use among a sample of first-year college women Perspect Sex Reprod Health 46 2 2014 73 81
45. R.L. Goldstein, U.D. Upadhyay, and T.R. Raine With pills, patches, rings, and shots: who still uses condoms? A longitudinal cohort study J Adolesc Health 52 1 2013 77 82
46. M.A. Sayegh, J.D. Fortenberry, M. Shew, and D.P. Orr The developmental association of relationship quality, hormonal contraceptive choice and condom non-use among adolescent women J Adolesc Health 39 3 2006 388 395